Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 38  Show
  1. 1
    "Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden crystal protein."
    Than N.G., Sumegi B., Than G.N., Berente Z., Bohn H.
    Placenta 20:703-710(1999) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY.
    Category: Function, Expression, Sequences.
    Tissue: Placenta.
    Source: UniProtKB/Swiss-Prot (reviewed).
  2. 2
    "Placental protein 13 (PP13), a serum marker for pregnancy disorders."
    Admon A., Paltieli Y., Slotky R., Mandel S.
    Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
    Category: Sequences.
    Tissue: Placenta.
    Source: UniProtKB/Swiss-Prot (reviewed).
  3. 3
    Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY.
    Category: Function, Expression, Sequences.
    Tissue: Placenta.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 27 other entries.

  4. 4
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  5. 5
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Tissue: Placenta.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50448 other entries.

  6. 6
    "Purification and characterization of two new soluble placental tissue proteins (PP13 and PP17)."
    Bohn H., Kraus W., Winckler W.
    Oncodev. Biol. Med. 4:343-350(1983) [PubMed] [Europe PMC] [Abstract]
    Cited for: SUBUNIT.
    Category: Interaction.
    Tissue: Placenta.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  7. 7
    "Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13)."
    Visegrady B., Than N.G., Kilar F., Suemegi B., Than G.N., Bohn H.
    Protein Eng. 14:875-880(2001) [PubMed] [Europe PMC] [Abstract]
    Cited for: 3D-STRUCTURE MODELING.
    Category: Structure.
    Source: UniProtKB/Swiss-Prot (reviewed).
  8. 8
    "Galectin-13, a different prototype galectin, does not bind beta-galacto-sides and forms dimers via intermolecular disulfide bridges between Cys-136 and Cys-138."
    Su J., Wang Y., Si Y., Gao J., Song C., Cui L., Wu R., Tai G., Zhou Y.
    Sci. Rep. 8:980-980(2018) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 2-139 OF WILD TYPE AND MUTANT HIS-53, FUNCTION, DISULFIDE BOND, SUBUNIT, SUBCELLULAR LOCATION, MUTAGENESIS OF ARG-53; CYS-136 AND CYS-138.
    Category: Function, Subcellular Location, Pathology & Biotech, PTM / Processing, Interaction, Structure.
    Source: UniProtKB/Swiss-Prot (reviewed).
  9. 9
    Category: Subcellular Location, PTM / Processing, Interaction.
    Annotation: PP13/galectin-13 may have special haemostatic and immunobiological functions at the lining of the common feto-maternal blood-spaces or developmental role in the placenta.
    Source: GeneRIF:29124.

    This publication is mapped to 1 other entry.

  10. 10
    "First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction."
    Chafetz I., Kuhnreich I., Sammar M., Tal Y., Gibor Y., Meiri H., Cuckle H., Wolf M.
    Am. J. Obstet. Gynecol. 197:35.e1-7(2007) [PubMed] [Europe PMC] [Abstract]
    Category: Sequences.
    Annotation: screening of maternal PP13 levels in the first trimester is a promising diagnostic tool for the prediction of preeclampsia with high sensitivity and specificity.
    Source: GeneRIF:29124.

    This publication is mapped to 1 other entry.

  11. 11
    "First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes."
    Cowans N.J., Spencer K., Meiri H.
    Prenat. Diagn. 28:121-125(2008) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: Decreased levels of PP13 (placental protein 13) were not significantly correlated with the studied adverse pregnancy outcomes of intrauterine growth restriction preterm delivery low birth weight and intrauterine fetal demise.
    Source: GeneRIF:29124.

    This publication is mapped to 1 other entry.

  12. 12
    Category: Sequences.
    Annotation: Maternal serum PP13 concentration in the first trimester was significantly lower in patients who developed preterm and early-onset preeclampsia than in those with normal pregnancies.
    Source: GeneRIF:29124.

    This publication is mapped to 1 other entry.

  13. 13
    "Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome."
    Than N.G., Abdul Rahman O., Magenheim R., Nagy B., Fule T., Hargitai B., Sammar M., Hupuczi P., Tarca A.L., Szabo G., Kovalszky I., Meiri H., Sziller I., Rigo J. Jr., Romero R., Papp Z.
    Virchows Arch. 453:387-400(2008) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Expression, Sequences.
    Annotation: parallel to its decreased placental expression an augmented membrane shedding of PP13 contributes to the increased third trimester maternal serum PP13 concentrations in women with preterm pre-eclampsia and HELLP syndrome.
    Source: GeneRIF:29124.

    This publication is mapped to 1 other entry.

  14. 14
    "PP13 mRNA expression in trophoblasts from preeclamptic placentas."
    Sekizawa A., Purwosunu Y., Yoshimura S., Nakamura M., Shimizu H., Okai T., Rizzo N., Farina A.
    Reprod Sci 16:408-413(2009) [PubMed] [Europe PMC] [Abstract]
    Category: Expression.
    Annotation: findings indicate that an alteration in the placental protein 13 (PP13) messenger RNA expression in the trophoblasts may be associated with the pathogenesis of preeclampsia.
    Source: GeneRIF:29124.

    This publication is mapped to 1 other entry.

  15. 15
    "Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia."
    Akolekar R., Syngelaki A., Beta J., Kocylowski R., Nicolaides K.H.
    Prenat. Diagn. 29:1103-1108(2009) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PP13 is implicated in the pathogenesis of impaired placentation and subsequent development of early-preeclampsia but measurement of this placental product is unlikely to be useful in screening for the disease at 11-13 weeks.
    Source: GeneRIF:29124.

    This publication is mapped to 1 other entry.

  16. 16
    "PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsia."
    Shimizu H., Sekizawa A., Purwosunu Y., Nakamura M., Farina A., Rizzo N., Okai T.
    Prenat. Diagn. 29:1231-1236(2009) [PubMed] [Europe PMC] [Abstract]
    Category: Expression, Sequences.
    Annotation: level in preeclampsia was significantly lower than that in controls.
    Source: GeneRIF:29124.

    This publication is mapped to 1 other entry.

  17. 17
    "A novel exonic variant (221delT) in the LGALS13 gene encoding placental protein 13 (PP13) is associated with preterm labour in a low risk population."
    Gebhardt S., Bruiners N., Hillermann R.
    J. Reprod. Immunol. 82:166-173(2009) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech, Sequences.
    Annotation: gene polymorphism is associated with an increased risk of preterm labour; Observational study of gene-disease association. (HuGE Navigator). [GeneRIF:29124]. Associated with REPRODUCTION: preterm labour. [GAD:564604].
    Source: GeneRIF:29124, GAD:564604.

    This publication is mapped to 27 other entries.

  18. 18
    "Placental protein 13 as a first trimester screening marker for aneuploidy."
    Koster M.P., Wortelboer E.J., Cuckle H.S., Stoutenbeek P., Visser G.H., Schielen P.C.
    Prenat. Diagn. 29:1237-1241(2009) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Pathology & Biotech.
    Annotation: multiples of the gestation-specific normal median significantly lower in trisomy 18 and 13 pregnancies.
    Source: GeneRIF:29124.

    This publication is mapped to 1 other entry.

  19. 19
    "PP13 stability in first trimester maternal serum and whole blood."
    Cowans N.J., Stamatopoulou A., Jaakohuhta S., Hentunen S., Spencer K.
    Prenat. Diagn. 30:582-585(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PP13 is a suitable stable molecule and can be treated under routine laboratory and transport temperatures.
    Source: GeneRIF:29124.

    This publication is mapped to 1 other entry.

  20. 20
    "Placenta-bound and body fluid PP13 and its mRNA in normal pregnancy compared to preeclampsia, HELLP and preterm delivery."
    Sammar M., Nisemblat S., Fleischfarb Z., Golan A., Sadan O., Meiri H., Huppertz B., Gonen R.
    Placenta 32 Suppl:S30-6(2011) [PubMed] [Europe PMC] [Abstract]
    Category: Expression, Sequences.
    Annotation: PP13 mRNA is lower in the third trimester at the time of disease while protein level accumulates and become higher creating an unparallel change in the level of the mRNA and the corresponding protein.
    Source: GeneRIF:29124.

    This publication is mapped to 1 other entry.

  21. 21
    "PP13 as a marker of pre-eclampsia: A two platform comparison study."
    Cowans N.J., Stamatopoulou A., Khalil A., Spencer K.
    Placenta 32 Suppl:S37-41(2011) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PP13 levels were decreased in women with preeclampsia.
    Source: GeneRIF:29124.

    This publication is mapped to 1 other entry.

  22. 22
    Category: Interaction.
    Source: IntAct:Q9UHV8.

    This publication is mapped to 793 other entries.

  23. 23
    "Placental protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome."
    Balogh A., Pozsgay J., Matko J., Dong Z., Kim C.J., Varkonyi T., Sammar M., Rigo J. Jr., Meiri H., Romero R., Papp Z., Than N.G.
    Am. J. Obstet. Gynecol. 205:156.e1-14(2011) [PubMed] [Europe PMC] [Abstract]
    Category: Subcellular Location.
    Annotation: PP13 is released from the syncytiotrophoblast in preterm preeclampsia and HELLP mimicked in BeWo cells by ischemic stress suggesting PP13 is a placental alarmin.
    Source: GeneRIF:29124.

    This publication is mapped to 1 other entry.

  24. 24
    "First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia."
    Odibo A.O., Zhong Y., Goetzinger K.R., Odibo L., Bick J.L., Bower C.R., Nelson D.M.
    Placenta 32:598-602(2011) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Annotation: PP13 was best in predicting early onset pre-eclampsia with a sensitivity of 79% at a 20% false positive rate.
    Source: GeneRIF:29124.

    This publication is mapped to 1 other entry.

  25. 25
    Category: Function.
    Annotation: ABO blood group can alter PP13-bioavailability in blood.
    Source: GeneRIF:29124.

    This publication is mapped to 1 other entry.

1 to 25 of 38  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again